Literature DB >> 17504212

The role of neurotrophins in axonal growth, guidance, and regeneration.

Marios G Lykissas1, Anna K Batistatou, Konstantinos A Charalabopoulos, Alexandros E Beris.   

Abstract

Neurotrophins are proteins that regulate neuronal survival, axonal growth, synaptic plasticity and neurotransmission. They are members of the neurotrophic factors family and include factors such as the nerve growth factor (NGF), the brain derived neurotrophic factor (BDNF), the neurotrophin-3 (NT-3), and the neurotrophin-4/5 (NT-4/5). These molecules bind to two types of receptors: i) tyrosine kinase receptors (TrkA, TrkB, TrkC) and ii) a common neurotrophin receptor (p75NTR). The two receptor types can either suppress or enhance each other's actions. Neurotrophins have a multifunctional role both in the central and peripheral nervous system. They have been suggested as axonal guidance molecules during the growth and regeneration of nerves. It has also been proven that they stimulate axonal growth by mediating the polymerization and accumulation of F-actin in growth cones and axon shafts. Neurotrophins, as other neurotrophic factors, have been shown that they reduce neuronal injury by exposure to excitotoxins, glucose deprivation, or ischemia. Furthermore, the nerve regeneration promoting effect of these growth factors is well documented for many different models of central or peripheral nervous system injury. Several studies have shown that exogenous administration of these factors has protective properties for injured neurons and stimulates axonal regeneration. Based on these properties, these molecules may be used as therapeutic agents for treating degenerative diseases and traumatic injuries of both the central and peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504212     DOI: 10.2174/156720207780637216

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  86 in total

1.  Mice deficient in brain-derived neurotrophic factor have altered development of gastric vagal sensory innervation.

Authors:  Michelle C Murphy; Edward A Fox
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 2.  Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.

Authors:  Kenneth Hensley; Kalina Venkova; Alexandar Christov; William Gunning; Joshua Park
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 3.  Neurotrophins in lung health and disease.

Authors:  Ys Prakash; Michael A Thompson; Lucas Meuchel; Christina M Pabelick; Carlos B Mantilla; Syed Zaidi; Richard J Martin
Journal:  Expert Rev Respir Med       Date:  2010-06       Impact factor: 3.772

4.  Fas and FasL expression in the spinal cord following cord hemisection in the monkey.

Authors:  Liu Jia; Zou Yu; Li Hui; Guan Yu-Guang; Zhou Xin-Fu; You Chao; Xiyang Yanbin; Zhan Xi; Wang Jun; Heng Xin-Hua; Hen Xin-Hua; Wang Ting-Hua
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

5.  Motoneuron programmed cell death in response to proBDNF.

Authors:  Anna R Taylor; David J Gifondorwa; Mac B Robinson; Jane L Strupe; David Prevette; James E Johnson; Barbara Hempstead; Ronald W Oppenheim; Carolanne E Milligan
Journal:  Dev Neurobiol       Date:  2012-05       Impact factor: 3.964

6.  Designing in vivo concentration gradients with discrete controlled release: a computational model.

Authors:  Edgar Y Walker; Dennis L Barbour
Journal:  J Neural Eng       Date:  2010-07-19       Impact factor: 5.379

7.  Comparison of a distal end-to-side neurorrhaphy with a proximal-distal end-to-side neurorrhaphy: in a rat model.

Authors:  Mohammad Ali Hosseinian; Ali Gharibi Loron; Behzad Nemati; Mohsen Khandaghy
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-07

Review 8.  Role of adenomatous polyposis coli (APC) and microtubules in directional cell migration and neuronal polarization.

Authors:  Angela I M Barth; Hector Y Caro-Gonzalez; W James Nelson
Journal:  Semin Cell Dev Biol       Date:  2008-02-23       Impact factor: 7.727

9.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

10.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Oscar Yanes; Ray Gariano; John Heckenlively; Eyal Banin; G Anthony Ramirez; Mehdi Gasmi; Alan Bird; Gary Siuzdak; Martin Friedlander
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.